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Hypoparathyroidism, 153 LOD score(s), 133, 735 (L), 738 (L)
Los Angeles variant, 366Hypophosphatemia, 790
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Method of mod scores, 217 Detection, 63, 1411, 1542 (L)
Dynamic, 993 (L)Methylation, 244 (L), 751 (E), 1354, 1558 (L)
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Nijmegen breakage syndrome, 605, 1246 (L), 1487 Phosphatidylinositols, 1384
Phosphoinositides, 1384Nondirectiveness, 40
Non–insulin-dependent diabetes, 188, 288 (L), 651, Phylogenetic analysis, 1107
Phylogenetic estimation, 755 (E)1532 (L)
Nonisotopic RNase cleavage assay, 1399 Physical mapping, 1139
Pima Indians, 166, 651Non-Jewish, 1099
Nonsense, 1122 PKD1, 1399
PKU (phenylketonuria), 95, 388Mutation, 729 (L)
Nonsyndromic hearing loss, 1168 Placental mosaicism, 917
Point mutation(s), 63, 555Nucleotide excision repair, 320
Polycystic kidney disease, 1399
Polygenic disease, 381Obesity, 143, 166, 188
OCRL1 gene, 1384 Polygenic trait, 1552 (L)
Polymorphism, 1532 (L)Oculocerebrorenal syndrome, Lowe, 1384
Odds ratios, 439 Base substitution, 1174
Polypyrimidine tract, 1389Ojibwa, 241 (L)
185delAG mutation, 1085 Population(s), 197, 447, 1013 (E), 1532 (L)
Aboriginal, 1552 (L)Onset, 630
Onychoosteodysplasis, 133 African, 755 (E)
African American, 1233 (L)Oocytes, 408, 1495
Optic neuropathy, 272 (E) Ashkenazi, 505, 1085
Asian, 676, 755, 1174Orotic aciduria, heretary, 525
Osseous tissue, 1309 (E) British, 388, 474
Centenarian, 999 (L)Osteoporosis, 1309 (E)
Osteosclerosis, 1309 (E) Danish, 1532 (L)
European, 1107, 1174Ovarian cancer, 496, 505, 1021, 1041, 1068, 1085,
1233 (L), 1239 (L), 1242 (L) Finnish, 1050, 1174
French, 1021, 1236 (L)Oxidative stress, 228 (L)
Genetics, 1174, 1513
Hungarian, 1242 (L)p44, 72
PAH mutations, 95 Icelandic, 1079
Italian, 828Panhypopituitarism, 910
Paracentric inversion, 1184 Japanese, 565, 732 (L)
Jewish, 1059Paraganglioma, 121
Parental gender, 460 (L) Native American, 241 (L)
Ojibwa, 241 (L)Parental origin, 230 (L), 233 (L)
Parkinson disease, 588 Russian, 1239 (L)
Scandinavian, 1068Parkinsonism, 588
patched mutation, 10 (E) Screening, 935
Population-based genetic testing, 1085PATCHED (PTCH, human homologue of Drosophila
patched gene), 21 Population-speciﬁc alleles, 957
Porphobilinogen deaminase gene, 1373PAX2, 869
PCR, 935 Porphyria, 1373
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Risk assessment, 910 Defects, 547
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Levels, 87 Statistical power, 676
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Sarcoglycans, 891 Gene(s), 1068, 1158
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Breast and ovarian cancer, 1085 691, 1006
Telomere healing, 113Genetic, 1099
Segregation, 1430, 1495 Terminal microdeletion, 113
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Seizures, 667 TIMP3 (tissue inhibitor of metalloproteinase-3), 57
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Transmission-disequilibrium test(s), 188, 191, 676, 691,
1006 (L) Variant alleles, 197
Treacher Collins syndrome, 515 VCFS (velo-cardio-facial syndrome), 851, 1194
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Triplasmy, 1430 Vitamins, 433
Triplet repeat(s), 730 (L), 1251 (L) VNTR, 95
Instability, 103 Von Hippel–Lindau disease/syndrome, 751 (L), 765
Trisomy, 917
tRNA mutation, 373 Werdnig-Hoffman disease, 72
Truncating mutations, 21 Werner syndrome, 330
Tumor suppressor, 305 Wilson disease, 1423
Gene, 21
Tumorigenesis, 305, 751 (E), 765
Xeroderma pigmentosum, 320Tunisian Jew, 103
Turkish family, 732 (L)
YAC contig, 860Twin(s), 143, 433, 638
Studies, 1502
Type 1 diabetes, 174 Zellweger syndrome, 1535 (L)
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